Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September.

DC Mtg: Learn How to Avoid a Warning Letter

FDA Commissioner Margaret Hamburg has taken steps to improve the effectiveness of FDA's enforcement system. As a result, medical device firms are reporting that FDA investigators are being more assertive when inspecting firms, increasing the number of 483 observations and issuing more warning letters.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

On October 5 - 6, AdvaMed is holding a workshop, "Avoiding a Warning Letter in FDA's New Enforcement Environment," in Washington DC. During the workshop, current and former FDA officials, lawyers, and industry representatives will describe tools to help you avoid 483 observations and warning letters. They will also provide guidance on how to respond to a warning letter should you get one.

What You Will Learn:

* FDA's criteria for issuing 483s and warning letters
* What to do when FDA makes an unorthodox request for records
* Do's and don'ts for handling an FDA inspection
* How to respond when FDA lists numerous insignificant items on a 483
* Ways to avoid common mistakes when annotating a 483
* How to conduct effective training
* How to determine FDA's inspection priorities using FOI
* Tips for creating CAPA records that reflect your commitment to compliance
* How to respond to 483s and warning Letters

Faculty:

* David R. Kalins, Special Assistant to the Director of the Office of Compliance, CDRH
* Betty Collins, former Director, FDA's Office of Enforcement 2
* Marlene Bobka, Vice President, FOI Services
* Judy Meritz, Shareholder, Baker Donaldson
* Tim Mohn, former Manager, Worldwide Quality Systems, Ortho-Clinical Diagnostics
* Nicole Petty, Senior Manager, Learning & Development, Stryker Instruments
* Javad Seyedzadeh, Senior Vice President Global Quality, Gambro
* Nancy Singer, former Special Counsel, AdvaMed

Cost:

$1195 AdvaMed members
$ 695 AdvaMed EGC member (less than 30 million in sales)
$1595 Non-member of AdvaMed

For more information go to:

http://www.advamedmtli.org/go.cfm?do=Wercs.Display&WID=118
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO